Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marcelo Garrido Salvo"'
Autor:
Elizabeth Gibson, Sara Lonardi, Christopher Jackson, Armando Santoro, Jose Manuel Trigo Perez, Iwona Lugowska, R Donald Harvey, Anne O’Donnell, Richard North, Loes Maria Latten-Jansen, Marcelo Garrido Salvo, Matías Chacón, Linghui Li, Devanand Joseph, Bryan Bennett, Balmeet Gurm, Wee-Teck Ng, Aitana Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2f70d683c2e141698475c6eae60259f3
Autor:
Herbert Hurwitz, Vaibhav Sahai, Chris Verslype, Jason Clark, Johanna C. Bendell, Ashwin Reddy Sama, Eric Van Cutsem, Manuel Hidalgo, Edward W Greeno, Eileen M. O'Reilly, Chung Pin Li, Kenneth H. Yu, Christopher James Walker, Fitzroy Dawkins, Teresa Macarulla, Marcelo Garrido Salvo
Publikováno v:
Investigational New Drugs. 36:683-695
Background Ruxolitinib, a Janus kinase 1 (JAK1)/JAK2 inhibitor, plus capecitabine improved overall survival (OS) vs capecitabine in a subgroup analysis of patients with metastatic pancreatic cancer and systemic inflammation (C-reactive protein [CRP]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4efb9dd95fab56ab09c97a08030248f
https://doi.org/10.1007/s10637-018-0580-2
https://doi.org/10.1007/s10637-018-0580-2
Autor:
Hurwitz, Herbert, Van Cutsem, Eric, Bendell, Johanna, Hidalgo, Manuel, Li, Chung-Pin, Salvo, Marcelo Garrido, Macarulla, Teresa, Sahai, Vaibhav, Sama, Ashwin, Greeno, Edward, Yu, Kenneth H., Verslype, Chris, Dawkins, Fitzroy, Walker, Chris, Clark, Jason, O’Reilly, Eileen M.
Publikováno v:
Investigational New Drugs; Aug2018, Vol. 36 Issue 4, p683-695, 13p